Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D08KJN
|
||||
| Former ID |
DNC013794
|
||||
| Drug Name |
Phenethylcarbamic Acid Biphenyl-3-yl Ester
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529498] | ||
| Formula |
C21H19NO2
|
||||
| Canonical SMILES |
C1=CC=C(C=C1)CCNC(=O)OC2=CC=CC(=C2)C3=CC=CC=C3
|
||||
| InChI |
1S/C21H19NO2/c23-21(22-15-14-17-8-3-1-4-9-17)24-20-13-7-12-19(16-20)18-10-5-2-6-11-18/h1-13,16H,14-15H2,(H,22,23)
|
||||
| InChIKey |
SYRRFVWOILIONB-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529498] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.